Inovio Pharmaceuticals (INO) Competitors $1.84 -0.01 (-0.27%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends INO vs. DRTS, PROF, UTMD, SKIN, ARAY, KRMD, OBIO, INFU, SGHT, and BWAYShould you be buying Inovio Pharmaceuticals stock or one of its competitors? The main competitors of Inovio Pharmaceuticals include Alpha Tau Medical (DRTS), Profound Medical (PROF), Utah Medical Products (UTMD), Beauty Health (SKIN), Accuray (ARAY), KORU Medical Systems (KRMD), Orchestra BioMed (OBIO), InfuSystem (INFU), Sight Sciences (SGHT), and BrainsWay (BWAY). These companies are all part of the "surgical & medical instruments" industry. Inovio Pharmaceuticals vs. Alpha Tau Medical Profound Medical Utah Medical Products Beauty Health Accuray KORU Medical Systems Orchestra BioMed InfuSystem Sight Sciences BrainsWay Alpha Tau Medical (NASDAQ:DRTS) and Inovio Pharmaceuticals (NASDAQ:INO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment, earnings and community ranking. Do analysts rate DRTS or INO? Alpha Tau Medical currently has a consensus target price of $8.00, suggesting a potential upside of 158.06%. Inovio Pharmaceuticals has a consensus target price of $38.00, suggesting a potential upside of 1,965.22%. Given Inovio Pharmaceuticals' higher probable upside, analysts plainly believe Inovio Pharmaceuticals is more favorable than Alpha Tau Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Tau Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Inovio Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has more volatility and risk, DRTS or INO? Alpha Tau Medical has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Comparatively, Inovio Pharmaceuticals has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500. Is DRTS or INO more profitable? Alpha Tau Medical's return on equity of -38.62% beat Inovio Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Alpha Tau MedicalN/A -38.62% -29.89% Inovio Pharmaceuticals N/A -118.17%-83.47% Does the MarketBeat Community believe in DRTS or INO? Inovio Pharmaceuticals received 700 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. Likewise, 71.19% of users gave Inovio Pharmaceuticals an outperform vote while only 70.37% of users gave Alpha Tau Medical an outperform vote. CompanyUnderperformOutperformAlpha Tau MedicalOutperform Votes1970.37% Underperform Votes829.63% Inovio PharmaceuticalsOutperform Votes71971.19% Underperform Votes29128.81% Which has better valuation and earnings, DRTS or INO? Alpha Tau Medical has higher earnings, but lower revenue than Inovio Pharmaceuticals. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Tau MedicalN/AN/A-$29.16M-$0.43-7.21Inovio Pharmaceuticals$203.41K236.09-$135.12M-$3.46-0.53 Do insiders & institutionals have more ownership in DRTS or INO? 2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 26.8% of Inovio Pharmaceuticals shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Comparatively, 2.5% of Inovio Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media favor DRTS or INO? In the previous week, Alpha Tau Medical had 5 more articles in the media than Inovio Pharmaceuticals. MarketBeat recorded 5 mentions for Alpha Tau Medical and 0 mentions for Inovio Pharmaceuticals. Inovio Pharmaceuticals' average media sentiment score of 0.09 beat Alpha Tau Medical's score of -0.11 indicating that Inovio Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Alpha Tau Medical Neutral Inovio Pharmaceuticals Neutral SummaryAlpha Tau Medical and Inovio Pharmaceuticals tied by winning 8 of the 16 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Inovio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INO vs. The Competition Export to ExcelMetricInovio PharmaceuticalsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$48.02M$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E Ratio-0.5325.3789.8217.18Price / Sales236.0945.921,116.21116.95Price / CashN/A43.4542.8937.86Price / Book0.367.094.784.78Net Income-$135.12M$13.64M$120.23M$225.60M7 Day Performance-20.69%-2.93%-1.92%-1.23%1 Month Performance-54.68%0.28%11.49%3.36%1 Year Performance-96.88%40.76%30.57%16.60% Inovio Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INOInovio Pharmaceuticals3.3185 of 5 stars$1.84-0.3%$38.00+1,965.2%-96.7%$48.02M$203,413.00-0.53127High Trading VolumeDRTSAlpha Tau Medical1.9713 of 5 stars$3.08+0.3%$8.00+159.7%+10.3%$215.37MN/A-7.1480PROFProfound Medical2.5362 of 5 stars$7.13-3.6%$13.75+92.8%-12.8%$214.11M$7.20M-5.52150UTMDUtah Medical Products2.9119 of 5 stars$62.95+0.5%N/A-27.9%$213.40M$50.22M14.73180Positive NewsSKINBeauty Health1.6194 of 5 stars$1.59+0.3%$2.55+60.9%-54.1%$196.73M$398M-3.761,030ARAYAccuray4.5748 of 5 stars$1.95+1.6%$9.00+361.5%-33.5%$196.10M$444.20M-11.29987News CoveragePositive NewsKRMDKORU Medical Systems1.3182 of 5 stars$4.27-0.7%$4.13-3.4%+74.0%$195.74M$28.52M-17.2080OBIOOrchestra BioMed2.0645 of 5 stars$5.14-2.3%$15.75+206.4%-49.8%$195.39M$2.65M-3.2756News CoverageINFUInfuSystem1.5723 of 5 stars$9.09+2.0%$13.00+43.0%N/A$193.29M$132.78M148.50499SGHTSight Sciences3.389 of 5 stars$3.69+3.1%$5.12+38.8%+7.2%$187.30M$81.06M-3.51210News CoverageBWAYBrainsWay3.9057 of 5 stars$9.55+1.4%$13.17+37.9%+40.9%$159.28M$38.63M95.20120 Related Companies and Tools Related Companies Alpha Tau Medical Alternatives Profound Medical Alternatives Utah Medical Products Alternatives Beauty Health Alternatives Accuray Alternatives KORU Medical Systems Alternatives Orchestra BioMed Alternatives InfuSystem Alternatives Sight Sciences Alternatives BrainsWay Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
